Handbook of HER2-Targeted Agents in Breast Cancer

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targete...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Alvarez, Ricardo H. (Συγγραφέας), Cortés, Javier (Συγγραφέας), Falzon, Mary (Συγγραφέας), Gandy, Michael (Συγγραφέας), Gianni, Luca (Συγγραφέας), Harbeck, Nadia (Συγγραφέας), Piccart, Martine (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Adis, 2016.
Έκδοση:2nd ed. 2016.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02642nam a22005415i 4500
001 978-3-319-28216-9
003 DE-He213
005 20160514101356.0
007 cr nn 008mamaa
008 160514s2016 gw | s |||| 0|eng d
020 |a 9783319282169  |9 978-3-319-28216-9 
024 7 |a 10.1007/978-3-319-28216-9  |2 doi 
040 |d GrThAP 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 616.994  |2 23 
100 1 |a Alvarez, Ricardo H.  |e author. 
245 1 0 |a Handbook of HER2-Targeted Agents in Breast Cancer  |h [electronic resource] /  |c by Ricardo H Alvarez, Javier Cortés, Mary Falzon, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart. 
250 |a 2nd ed. 2016. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Adis,  |c 2016. 
300 |a XI, 110 p. 17 illus., 16 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction and background biology -- HER2 testing -- HER2-positive breast cancer: neoadjuvant and adjuvant therapy -- HER2-positive metastatic breast cancer: first-line treatment -- HER2-positive metastatic breast cancer: second-line treatment -- Emerging targeted agents for HER2-positive breast cancer. 
520 |a This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape. 
650 0 |a Medicine. 
650 0 |a Radiology. 
650 0 |a Oncology. 
650 0 |a Primary care (Medicine). 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Oncology. 
650 2 4 |a Primary Care Medicine. 
650 2 4 |a Diagnostic Radiology. 
700 1 |a Cortés, Javier.  |e author. 
700 1 |a Falzon, Mary.  |e author. 
700 1 |a Gandy, Michael.  |e author. 
700 1 |a Gianni, Luca.  |e author. 
700 1 |a Harbeck, Nadia.  |e author. 
700 1 |a Piccart, Martine.  |e author. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319282145 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-28216-9  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)